Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery [Phase 3]

View source ↗

Summary

This update reports results from a Phase 3 trial of pazopanib hydrochloride in patients with metastatic renal cell carcinoma who have no evidence of disease aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-07-19